- REPORT SUMMARY
- TABLE OF CONTENTS
-
Endometriosis affects an estimated 1 in 10 women in the reproductive age group of 15-49 years.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Endometriosis Drugs market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Endometriosis Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Endometriosis Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
ValiRx
Takeda Pharmaceutical Company Limited
Kissei Pharmaceutical
Evotec AG
Repros Therapeutics
AbbVie
Astellas Pharma
Roivant Sciences GmbH
ObsEva
Neurocrine Biosciences
AstraZeneca
Debiopharm Group
Pfizer
By Type:
Hormonal Therapy
Add-back Medication
Progestogens
Chinese Herbs
By End-User:
Hospitals
Clinics
Research Institutes
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Endometriosis Drugs Market
-
1.3 Market Segment by Type
-
1.3.1 USA Endometriosis Drugs Market Size and Growth Rate of Hormonal Therapy from 2016 to 2027
-
1.3.2 USA Endometriosis Drugs Market Size and Growth Rate of Add-back Medication from 2016 to 2027
-
1.3.3 USA Endometriosis Drugs Market Size and Growth Rate of Progestogens from 2016 to 2027
-
1.3.4 USA Endometriosis Drugs Market Size and Growth Rate of Chinese Herbs from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Endometriosis Drugs Market Size and Growth Rate of Hospitals from 2016 to 2027
-
1.4.2 USA Endometriosis Drugs Market Size and Growth Rate of Clinics from 2016 to 2027
-
1.4.3 USA Endometriosis Drugs Market Size and Growth Rate of Research Institutes from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Endometriosis Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Endometriosis Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Endometriosis Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Endometriosis Drugs Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Endometriosis Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Endometriosis Drugs by Major Types
-
3.4.1 Market Size and Growth Rate of Hormonal Therapy
-
3.4.2 Market Size and Growth Rate of Add-back Medication
-
3.4.3 Market Size and Growth Rate of Progestogens
-
3.4.4 Market Size and Growth Rate of Chinese Herbs
4 Segmentation of Endometriosis Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Endometriosis Drugs by Major End-Users
-
4.4.1 Market Size and Growth Rate of Endometriosis Drugs in Hospitals
-
4.4.2 Market Size and Growth Rate of Endometriosis Drugs in Clinics
-
4.4.3 Market Size and Growth Rate of Endometriosis Drugs in Research Institutes
5 Market Analysis by Regions
-
5.1 USA Endometriosis Drugs Production Analysis by Regions
-
5.2 USA Endometriosis Drugs Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Endometriosis Drugs Landscape Analysis
-
6.1 West USA Endometriosis Drugs Landscape Analysis by Major Types
-
6.2 West USA Endometriosis Drugs Landscape Analysis by Major End-Users
7 South USA Endometriosis Drugs Landscape Analysis
-
7.1 South USA Endometriosis Drugs Landscape Analysis by Major Types
-
7.2 South USA Endometriosis Drugs Landscape Analysis by Major End-Users
8 Middle West USA Endometriosis Drugs Landscape Analysis
-
8.1 Middle West USA Endometriosis Drugs Landscape Analysis by Major Types
-
8.2 Middle West USA Endometriosis Drugs Landscape Analysis by Major End-Users
9 Northeast USA Endometriosis Drugs Landscape Analysis
-
9.1 Northeast USA Endometriosis Drugs Landscape Analysis by Major Types
-
9.2 Northeast USA Endometriosis Drugs Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 ValiRx
-
10.1.1 ValiRx Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Takeda Pharmaceutical Company Limited
-
10.2.1 Takeda Pharmaceutical Company Limited Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Kissei Pharmaceutical
-
10.3.1 Kissei Pharmaceutical Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Evotec AG
-
10.4.1 Evotec AG Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Repros Therapeutics
-
10.5.1 Repros Therapeutics Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 AbbVie
-
10.6.1 AbbVie Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Astellas Pharma
-
10.7.1 Astellas Pharma Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Roivant Sciences GmbH
-
10.8.1 Roivant Sciences GmbH Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 ObsEva
-
10.9.1 ObsEva Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Neurocrine Biosciences
-
10.10.1 Neurocrine Biosciences Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 AstraZeneca
-
10.11.1 AstraZeneca Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
-
10.12 Debiopharm Group
-
10.12.1 Debiopharm Group Company Profile and Recent Development
-
10.12.2 Market Performance
-
10.12.3 Product and Service Introduction
-
10.13 Pfizer
-
10.13.1 Pfizer Company Profile and Recent Development
-
10.13.2 Market Performance
-
10.13.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Endometriosis Drugs Market Size and Growth Rate of Hormonal Therapy from 2016 to 2027
-
Figure USA Endometriosis Drugs Market Size and Growth Rate of Add-back Medication from 2016 to 2027
-
Figure USA Endometriosis Drugs Market Size and Growth Rate of Progestogens from 2016 to 2027
-
Figure USA Endometriosis Drugs Market Size and Growth Rate of Chinese Herbs from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Endometriosis Drugs Market Size and Growth Rate of Hospitals from 2016 to 2027
-
Figure USA Endometriosis Drugs Market Size and Growth Rate of Clinics from 2016 to 2027
-
Figure USA Endometriosis Drugs Market Size and Growth Rate of Research Institutes from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Endometriosis Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Endometriosis Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Endometriosis Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Endometriosis Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Endometriosis Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Endometriosis Drugs
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Endometriosis Drugs by Different Types from 2016 to 2027
-
Table Consumption Share of Endometriosis Drugs by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Hormonal Therapy
-
Figure Market Size and Growth Rate of Add-back Medication
-
Figure Market Size and Growth Rate of Progestogens
-
Figure Market Size and Growth Rate of Chinese Herbs
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Endometriosis Drugs by Different End-Users from 2016 to 2027
-
Table Consumption Share of Endometriosis Drugs by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospitals
-
Figure Market Size and Growth Rate of Clinics
-
Figure Market Size and Growth Rate of Research Institutes
-
Table USA Endometriosis Drugs Production by Regions
-
Table USA Endometriosis Drugs Production Share by Regions
-
Figure USA Endometriosis Drugs Production Share by Regions in 2016
-
Figure USA Endometriosis Drugs Production Share by Regions in 2021
-
Figure USA Endometriosis Drugs Production Share by Regions in 2027
-
Table USA Endometriosis Drugs Consumption by Regions
-
Table USA Endometriosis Drugs Consumption Share by Regions
-
Figure USA Endometriosis Drugs Consumption Share by Regions in 2016
-
Figure USA Endometriosis Drugs Consumption Share by Regions in 2021
-
Figure USA Endometriosis Drugs Consumption Share by Regions in 2027
-
Table West USA Endometriosis Drugs Consumption by Types from 2016 to 2027
-
Table West USA Endometriosis Drugs Consumption Share by Types from 2016 to 2027
-
Figure West USA Endometriosis Drugs Consumption Share by Types in 2016
-
Figure West USA Endometriosis Drugs Consumption Share by Types in 2021
-
Figure West USA Endometriosis Drugs Consumption Share by Types in 2027
-
Table West USA Endometriosis Drugs Consumption by End-Users from 2016 to 2027
-
Table West USA Endometriosis Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Endometriosis Drugs Consumption Share by End-Users in 2016
-
Figure West USA Endometriosis Drugs Consumption Share by End-Users in 2021
-
Figure West USA Endometriosis Drugs Consumption Share by End-Users in 2027
-
Table South USA Endometriosis Drugs Consumption by Types from 2016 to 2027
-
Table South USA Endometriosis Drugs Consumption Share by Types from 2016 to 2027
-
Figure South USA Endometriosis Drugs Consumption Share by Types in 2016
-
Figure South USA Endometriosis Drugs Consumption Share by Types in 2021
-
Figure South USA Endometriosis Drugs Consumption Share by Types in 2027
-
Table South USA Endometriosis Drugs Consumption by End-Users from 2016 to 2027
-
Table South USA Endometriosis Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Endometriosis Drugs Consumption Share by End-Users in 2016
-
Figure South USA Endometriosis Drugs Consumption Share by End-Users in 2021
-
Figure South USA Endometriosis Drugs Consumption Share by End-Users in 2027
-
Table Middle West USA Endometriosis Drugs Consumption by Types from 2016 to 2027
-
Table Middle West USA Endometriosis Drugs Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Endometriosis Drugs Consumption Share by Types in 2016
-
Figure Middle West USA Endometriosis Drugs Consumption Share by Types in 2021
-
Figure Middle West USA Endometriosis Drugs Consumption Share by Types in 2027
-
Table Middle West USA Endometriosis Drugs Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Endometriosis Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Endometriosis Drugs Consumption Share by End-Users in 2016
-
Figure Middle West USA Endometriosis Drugs Consumption Share by End-Users in 2021
-
Figure Middle West USA Endometriosis Drugs Consumption Share by End-Users in 2027
-
Table Northeast USA Endometriosis Drugs Consumption by Types from 2016 to 2027
-
Table Northeast USA Endometriosis Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Endometriosis Drugs Consumption Share by Types in 2016
-
Figure Northeast USA Endometriosis Drugs Consumption Share by Types in 2021
-
Figure Northeast USA Endometriosis Drugs Consumption Share by Types in 2027
-
Table Northeast USA Endometriosis Drugs Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Endometriosis Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Endometriosis Drugs Consumption Share by End-Users in 2016
-
Figure Northeast USA Endometriosis Drugs Consumption Share by End-Users in 2021
-
Figure Northeast USA Endometriosis Drugs Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of ValiRx
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of ValiRx
-
Figure Sales and Growth Rate Analysis of ValiRx
-
Figure Revenue and Market Share Analysis of ValiRx
-
Table Product and Service Introduction of ValiRx
-
Table Company Profile and Development Status of Takeda Pharmaceutical Company Limited
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical Company Limited
-
Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical Company Limited
-
Figure Revenue and Market Share Analysis of Takeda Pharmaceutical Company Limited
-
Table Product and Service Introduction of Takeda Pharmaceutical Company Limited
-
Table Company Profile and Development Status of Kissei Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kissei Pharmaceutical
-
Figure Sales and Growth Rate Analysis of Kissei Pharmaceutical
-
Figure Revenue and Market Share Analysis of Kissei Pharmaceutical
-
Table Product and Service Introduction of Kissei Pharmaceutical
-
Table Company Profile and Development Status of Evotec AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Evotec AG
-
Figure Sales and Growth Rate Analysis of Evotec AG
-
Figure Revenue and Market Share Analysis of Evotec AG
-
Table Product and Service Introduction of Evotec AG
-
Table Company Profile and Development Status of Repros Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Repros Therapeutics
-
Figure Sales and Growth Rate Analysis of Repros Therapeutics
-
Figure Revenue and Market Share Analysis of Repros Therapeutics
-
Table Product and Service Introduction of Repros Therapeutics
-
Table Company Profile and Development Status of AbbVie
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie
-
Figure Sales and Growth Rate Analysis of AbbVie
-
Figure Revenue and Market Share Analysis of AbbVie
-
Table Product and Service Introduction of AbbVie
-
Table Company Profile and Development Status of Astellas Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma
-
Figure Sales and Growth Rate Analysis of Astellas Pharma
-
Figure Revenue and Market Share Analysis of Astellas Pharma
-
Table Product and Service Introduction of Astellas Pharma
-
Table Company Profile and Development Status of Roivant Sciences GmbH
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roivant Sciences GmbH
-
Figure Sales and Growth Rate Analysis of Roivant Sciences GmbH
-
Figure Revenue and Market Share Analysis of Roivant Sciences GmbH
-
Table Product and Service Introduction of Roivant Sciences GmbH
-
Table Company Profile and Development Status of ObsEva
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of ObsEva
-
Figure Sales and Growth Rate Analysis of ObsEva
-
Figure Revenue and Market Share Analysis of ObsEva
-
Table Product and Service Introduction of ObsEva
-
Table Company Profile and Development Status of Neurocrine Biosciences
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Neurocrine Biosciences
-
Figure Sales and Growth Rate Analysis of Neurocrine Biosciences
-
Figure Revenue and Market Share Analysis of Neurocrine Biosciences
-
Table Product and Service Introduction of Neurocrine Biosciences
-
Table Company Profile and Development Status of AstraZeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
-
Figure Sales and Growth Rate Analysis of AstraZeneca
-
Figure Revenue and Market Share Analysis of AstraZeneca
-
Table Product and Service Introduction of AstraZeneca
-
Table Company Profile and Development Status of Debiopharm Group
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Debiopharm Group
-
Figure Sales and Growth Rate Analysis of Debiopharm Group
-
Figure Revenue and Market Share Analysis of Debiopharm Group
-
Table Product and Service Introduction of Debiopharm Group
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-

Chinese